| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |